These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7779586)

  • 1. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1994; 15():190-212. PubMed ID: 7779586
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic response modifiers in chronic hepatitis C.
    Carreño V; Quiroga JA
    J Hepatol; 1995; 22(1 Suppl):122-6. PubMed ID: 7541408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1997; 17():287-315. PubMed ID: 9551217
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokines and biological response modifiers in the treatment of infection.
    Mueller BU; Pizzo PA
    Cancer Treat Res; 1998; 96():201-22. PubMed ID: 9711401
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on therapeutic activity of benzoxazinorifamycin KRM-1648 in combination with other antimicrobial agents and biological response modifiers interferon-gamma and granulocyte-macrophage colony-stimulating factor against M. leprae infection in athymic nude mice.
    Maw WW; Tomioka H; Sato K; Saito H
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):345-51. PubMed ID: 9401487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean myeloperoxidase index in lymphoma transplants receiving recombinant granulocyte-macrophage colony stimulating factor.
    Tsakona CP; Khwaja A; Goldstone AH
    Bone Marrow Transplant; 1993 Apr; 11(4):345-6. PubMed ID: 8387371
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rapid recovery after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF) for neutropenia caused by indomethacin].
    Costa RM; Leite J
    Sangre (Barc); 1993 Dec; 38(6):502-3. PubMed ID: 8171389
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological monitoring and clinical trials of biological response modifiers.
    Baseler MW; Kopp WC; Urba WJ
    Cancer Chemother Biol Response Modif; 1993; 14():249-83. PubMed ID: 7508729
    [No Abstract]   [Full Text] [Related]  

  • 9. [A drug delivery system and biological response modifiers for the treatment of mycobacterial infection].
    Koga H; Miyazaki Y; Kohno S; Hara K
    Kekkaku; 1994 Feb; 69(2):113-8. PubMed ID: 8126987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
    Hurtado R; Candelaria M; Majluf-Cruz A; Sosa-Camas RE; Labardini-Méndez J
    Rev Invest Clin; 1994; 46(1):59-61. PubMed ID: 8079066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma vaccines.
    Naylor MF
    Dermatol Online J; 2000 Sep; 6(1):5. PubMed ID: 11328615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
    Ganser A; Ottmann OG; Hoelzer D
    Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term disappearance of previous chromosomal abnormalities in myelodysplastic syndromes treated with low dose cytosine arabinoside and granulocyte/macrophage-colony stimulating factor.
    Sastre JL; Ulibarrena C; Bustillo M; Suárez-Gago M; García-Torremocha MS; Vázquez MO
    Haematologica; 1998 Aug; 83(8):763-5. PubMed ID: 9793271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic therapy in patients receiving salvage treatment.
    Bukowski RM
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):96-9. PubMed ID: 8091247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological response modifiers in cancer therapy.
    Gupta S; Kanodia AK
    Natl Med J India; 2002; 15(4):202-7. PubMed ID: 12296474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological monitoring and clinical trials of biological response modifiers.
    Kopp WC; Holmlund JT; Urba WJ
    Cancer Chemother Biol Response Modif; 1994; 15():226-86. PubMed ID: 7540029
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytokines in dermatology.
    Holman DM; Kalaaji AN
    J Drugs Dermatol; 2006 Jun; 5(6):520-4. PubMed ID: 16774103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1999; 18():223-38. PubMed ID: 10800485
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging concepts in GM-CSF gene-transduced tumor vaccines for human prostate cancer.
    Lim M; Simons JW
    Curr Opin Mol Ther; 1999 Feb; 1(1):64-71. PubMed ID: 11249686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.